IDIBELL (Institut d'investigació biomédica de Bellvitge)http://www.idibell.cat/en-enNoticies d'IDIBELLIDIBELLThe EPICUP Project receives a Pfizer Foundation Innovation award ]]>http://www.idibell.cat/modul/news/ca/1072/the-epicup-project-receives-a-pfizer-foundation-innovation-award2018-04-20Bringing research closer to the industry

IDIBELL celebrates the first edition of its Accelerator Meeting Point

]]>
http://www.idibell.cat/modul/news/ca/1070/bringing-research-closer-to-the-industry2018-04-17
A drug used in metabolic diseases is effective in the treatment of resistant tumors of testicular cancer ]]>http://www.idibell.cat/modul/news/ca/1071/a-drug-used-in-metabolic-diseases-is-effective-in-the-treatment-of-resistant-tumors-of-testicular-cancer2018-04-17IDIBELL redefines itself in its annual Retreat ]]>http://www.idibell.cat/modul/news/ca/1069/idibell-redefines-itself-in-its-annual-retreat2018-04-16Researchers describe the in vivo cooperation of the basolateral transporters LAT2 / CD98hc and TAT1 in the renal reabsorption of neutral amino acids ]]>http://www.idibell.cat/modul/news/ca/1068/researchers-describe-the-in-vivo-cooperation-of-the-basolateral-transporters-lat2-cd98hc-and-tat1-in-the-renal-reabsorption-of-neutral-amino-acids2018-04-17A potential new therapeutic target for Ewing sarcoma ]]>http://www.idibell.cat/modul/news/ca/1067/a-potential-new-therapeutic-target-for-ewing-sarcoma2018-04-05IDIBELL obtains the TECNIO certification as a public technology facilitator ]]>http://www.idibell.cat/modul/news/ca/1066/idibell-obtains-the-tecnio-certification-as-a-public-technology-facilitator2018-03-26The IDIBELL PhD Day grows stronger in its third edition ]]>http://www.idibell.cat/modul/news/ca/1065/the-idibell-phd-day-grows-stronger-in-its-third-edition2018-03-19Creation of a web platform for the identification of fronto-subcortical connectivity alterations in brain disorders ]]>http://www.idibell.cat/modul/news/ca/1064/creation-of-a-web-platform-for-the-identification-of-fronto-subcortical-connectivity-alterations-in-brain-disorders2018-03-15Un consorcio internacional liderado por investigadores catalanes descubre un nuevo gen llamado EDC4 implicado en el cáncer de mama familiar ]]>http://www.idibell.cat/modul/news/ca/1063/un-consorcio-internacional-liderado-por-investigadores-catalanes-descubre-un-nuevo-gen-llamado-edc4-implicado-en-el-cancer-de-mama-familiar2018-03-14IDIBELL’s researcher Manel Esteller is the most cited Spain-based biomedical scientist ]]>http://www.idibell.cat/modul/news/ca/1062/idibells-researcher-manel-esteller-is-the-most-cited-spain-based-biomedical-scientist2018-03-12Dr. Manel Esteller, Award for Innovation in the Healthcare Field in Oncology ]]>http://www.idibell.cat/modul/news/ca/1061/dr-manel-esteller-award-for-innovation-in-the-healthcare-field-in-oncology2018-03-01ICABELL, a new boost to the internationalization of IDIBELL’s research ]]>http://www.idibell.cat/modul/news/ca/1060/icabell-a-new-boost-to-the-internationalization-of-idibells-research2018-02-26Nobel Laureate Erwin Neher visits IDIBELL

The winner of the 1991 Nobel Prize for Medicine visits the institute and talks to its younger researchers

]]>
http://www.idibell.cat/modul/news/ca/1059/nobel-laureate-erwin-neher-visits-idibell2018-02-22
RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease ]]>http://www.idibell.cat/modul/news/ca/1058/rac1-protein-could-be-a-new-therapeutic-target-to-fight-neurodegeneration-in-parkinsons-disease2018-02-21ADmit Therapeutics becomes a new IDIBELL spin-off ]]>http://www.idibell.cat/modul/news/ca/1057/admit-therapeutics-becomes-a-new-idibell-spin-off2018-02-19Jornada sobre l’impacte de la biompressió, els nanorobots i la fotònica en la medicina ]]>http://www.idibell.cat/modul/news/ca/1056/jornada-sobre-limpacte-de-la-biompressio-els-nanorobots-i-la-fotonica-en-la-medicina2018-02-16El calendario solidario Helios recauda 2.900 € para la investigación del cáncer infantil en el IDIBELL ]]>http://www.idibell.cat/modul/news/ca/1055/el-calendario-solidario-helios-recauda-2900-para-la-investigacion-del-cancer-infantil-en-el-idibell2018-02-15Scientists prove the implication of an amino acid transporter in age-related deafness ]]>http://www.idibell.cat/modul/news/ca/1054/scientists-prove-the-implication-of-an-amino-acid-transporter-in-age-related-deafness2018-02-15The IT-LIVER European consortium expands TGF-beta knowledge in liver cancer ]]>http://www.idibell.cat/modul/news/ca/1053/the-it-liver-european-consortium-expands-tgf-beta-knowledge-in-liver-cancer2018-02-06Ciencia de cerca y en femenino: El IDIBELL y el CMR[B] celebran el 1er sLHam de Mujeres Científicas

El Auditorio Barradas de L'Hospitalet se llenó de público para acoger la singular propuesta con la que el IDIBELL y el CMR[B] conmemoraron el Día Internacional de la Mujer y la Niña en la Ciencia

]]>
http://www.idibell.cat/modul/news/ca/1052/ciencia-de-cerca-y-en-femenino-el-idibell-y-el-cmrb-celebran-el-1er-slham-de-mujeres-cientificas2018-02-05
Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer ]]>http://www.idibell.cat/modul/news/ca/1044/lex-vaquero-is-awarded-200000-euros-from-worldwide-cancer-research-to-better-understand-the-origin-of-cancer2018-01-10EU empowers four IDIBELL researchers with Marie Sklodowska-Curie Individual Fellowships

Four awarded grants from a call that has received more applications than ever before

]]>
http://www.idibell.cat/modul/news/ca/1051/eu-empowers-four-idibell-researchers-with-marie-sklodowska-curie-individual-fellowships2018-02-07
Successful first #Lindibell swing jam for biomedical research ]]>http://www.idibell.cat/modul/news/ca/1049/successful-first-lindibell-swing-jam-for-biomedical-research2018-01-29The Cátedra Extraordinaria del Dolor honors Francisco Ciruela for the design of the first photoactive drug with analgesic action ]]>http://www.idibell.cat/modul/news/ca/1050/the-catedra-extraordinaria-del-dolor-honors-francisco-ciruela-for-the-design-of-the-first-photoactive-drug-with-analgesic-action2018-01-29La ONCE y el IDIBELL avanzan en estudios genéticos para prevenir las distrofias de retina

Las distrofias hereditarias de la retina son desórdenes con gran heterogeneidad clínica y genética para los que no hay cura a día de hoy y que afectan 15000 personas en España

]]>
http://www.idibell.cat/modul/news/ca/1048/la-once-y-el-idibell-avanzan-en-estudios-geneticos-para-prevenir-las-distrofias-de-retina2018-01-23
Researchers identify a new NF-kB pathway regulatory mechanism linked to SirT6 ]]>http://www.idibell.cat/modul/news/ca/1047/researchers-identify-a-new-nf-kb-pathway-regulatory-mechanism-linked-to-sirt62018-01-18Conxi Lázaro, Juani Fernández and Alberto Villanueva receive an NF Research Initiative grant to test combination therapies in MPNST ]]>http://www.idibell.cat/modul/news/ca/1045/conxi-lazaro-juani-fernandez-and-alberto-villanueva-receive-an-nf-research-initiative-grant-to-test-combination-therapies-in-mpnst2018-01-16IDIBELL researchers successfully test a new combination therapy in sarcomas ]]>http://www.idibell.cat/modul/news/ca/1046/idibell-researchers-successfully-test-a-new-combination-therapy-in-sarcomas2018-01-11IDIBELL-ICO researchers identify a new therapeutic target to fight metastasis in ovarian cancer ]]>http://www.idibell.cat/modul/news/ca/1043/idibell-ico-researchers-identify-a-new-therapeutic-target-to-fight-metastasis-in-ovarian-cancer2018-01-04La solidaridad, protagonista de la Navidad en el IDIBELL

El Concierto de Navidad de L'Hospitalet, la Cursa dels Nassos de Barcelona y el Torneo de Baloncesto Cadete de Esplugues aportarán fondos para la formación de los jóvenes investigadores del IDIBELL

]]>
http://www.idibell.cat/modul/news/ca/1042/la-solidaridad-protagonista-de-la-navidad-en-el-idibell2017-12-22
Mild obsessive-compulsive symptoms are associated with variations of cerebral anatomy in healthy children ]]>http://www.idibell.cat/modul/news/ca/1041/mild-obsessive-compulsive-symptoms-are-associated-with-variations-of-cerebral-anatomy-in-healthy-children2017-12-19European project EU-TRAIN to improve the results in kidney transplant receives more than six million euros ]]>http://www.idibell.cat/modul/news/ca/1039/european-project-eu-train-to-improve-the-results-in-kidney-transplant-receives-more-than-six-million-euros2017-12-18A new model to overcome rejection in xenotransplantation ]]>http://www.idibell.cat/modul/news/ca/1040/a-new-model-to-overcome-rejection-in-xenotransplantation2017-12-18El calendario solidario Helios recauda fondos para la investigación del cáncer infantil en el IDIBELL ]]>http://www.idibell.cat/modul/news/ca/1038/el-calendario-solidario-helios-recauda-fondos-para-la-investigacion-del-cancer-infantil-en-el-idibell2017-12-11Se presentan los Bombones Carla: una iniciativa solidaria para promover la investigación del síndrome de Rett ]]>http://www.idibell.cat/modul/news/ca/1037/se-presentan-los-bombones-carla-una-iniciativa-solidaria-para-promover-la-investigacion-del-sindrome-de-rett2017-11-29Scientists identify the segmentation and consolidation mechanism of long-term memories ]]>http://www.idibell.cat/modul/news/ca/1036/scientists-identify-the-segmentation-and-consolidation-mechanism-of-long-term-memories2017-11-27El III Premio Martí Vía para la investigación oncológica recae al Programa ProCURE ]]>http://www.idibell.cat/modul/news/ca/1035/el-iii-premio-marti-via-para-la-investigacion-oncologica-recae-al-programa-procure2017-11-27International collaboration at the ''Amino acid transport defects'' symposium ]]>http://www.idibell.cat/modul/news/ca/1034/international-collaboration-at-the-amino-acid-transport-defects-symposium2017-11-28The isoforms of the HP1 protein differentially regulate the organization and structure of heterochromatin ]]>http://www.idibell.cat/modul/news/ca/1032/the-isoforms-of-the-hp1-protein-differentially-regulate-the-organization-and-structure-of-heterochromatin2017-11-20Each year in Catalonia, roughly 1,000 women die of breast cancer and 275 of ovarian cancer ]]>http://www.idibell.cat/modul/news/ca/1033/each-year-in-catalonia-roughly-1000-women-die-of-breast-cancer-and-275-of-ovarian-cancer2017-11-27''Best Ideas 2017'' award to Manel Esteller ]]>http://www.idibell.cat/modul/news/ca/1031/best-ideas-2017-award-to-manel-esteller2017-11-17Ramon Salazar receives funding for a research project on colon cancer

The Spanish Association Against Cancer (AECC) and the Carlos III Health Institute (ISCII) have decided to financially contribute to the 'Horizon 2020 TRASCAN' program of the European Union to fund five Spanish projects

]]>
http://www.idibell.cat/modul/news/ca/1029/ramon-salazar-receives-funding-for-a-research-project-on-colon-cancer2017-11-15
El IDIBELL y el Foro Empresarial del Llobregat dedican a la esclerosis múltiple su 2ª Noche Solidaria con la investigación biomédica ]]>http://www.idibell.cat/modul/news/ca/1030/el-idibell-y-el-foro-empresarial-del-llobregat-dedican-a-la-esclerosis-multiple-su-2-noche-solidaria-con-la-investigacion-biomedica2017-11-14The ‘Viladecans Against Cancer’ Association Coordinator raises 16.186 euros for stomach cancer research in IDIBELL ]]>http://www.idibell.cat/modul/news/ca/1027/the-viladecans-against-cancer-association-coordinator-raises-16186-euros-for-stomach-cancer-research-in-idibell2017-11-13Éxito del No Limits Barcelona, la gincana urbana de la conducción ecológica y sin barreras ]]>http://www.idibell.cat/modul/news/ca/1026/xito-del-no-limits-barcelona-la-gincana-urbana-de-la-conduccion-ecologica-y-sin-barreras2017-11-06La Marató 2016 gives the grants for research projects on ictus and traumatic spinal cord and brain injuries ]]>http://www.idibell.cat/modul/news/ca/1025/la-marato-2016-gives-the-grants-for-research-projects-on-ictus-and-traumatic-spinal-cord-and-brain-injuries2017-11-03Researchers prove the effectiveness of a new drug to prevent the onset and the pain of chemotherapy-induced neuropathy ]]>http://www.idibell.cat/modul/news/ca/1024/researchers-prove-the-effectiveness-of-a-new-drug-to-prevent-the-onset-and-the-pain-of-chemotherapy-induced-neuropathy2017-10-23Researchers identify neural mechanisms that strengthen or weaken memories during sleep ]]>http://www.idibell.cat/modul/news/ca/1023/researchers-identify-neural-mechanisms-that-strengthen-or-weaken-memories-during-sleep2017-10-11A new genetic marker accounts for up to 1.4% of cases of hereditary colon cancer ]]>http://www.idibell.cat/modul/news/ca/1022/a-new-genetic-marker-accounts-for-up-to-14-of-cases-of-hereditary-colon-cancer2017-10-09IDIBELL scientists identify a key regulator of the acquisition of immune tolerance to tumor cells in cancer patients ]]>http://www.idibell.cat/modul/news/ca/1021/idibell-scientists-identify-a-key-regulator-of-the-acquisition-of-immune-tolerance-to-tumor-cells-in-cancer-patients2017-09-28El Campus de Bellvitge acoge la exposición ‘María Sklodowska-Curie, una polaca en París’ ]]>http://www.idibell.cat/modul/news/ca/1020/el-campus-de-bellvitge-acoge-la-exposicion-maria-sklodowska-curie-una-polaca-en-paris2017-09-27Success of the “H2020 Opportunities” informative session ]]>http://www.idibell.cat/modul/news/ca/1018/success-of-the-h2020-opportunities-informative-session2017-09-22Communiqué from the universities and research centres of Catalonia ]]>http://www.idibell.cat/modul/news/ca/1019/communique-from-the-universities-and-research-centres-of-catalonia2017-09-22A group of lymphangioleiomyomatosis (LAM) patients attend a talk on the disease and advances

David J. Kwiatkowski, a professor of medicine at Harvard University and an oncologist specializing in thoracic oncology at Dana-Farber Cancer Institute in Boston, was responsible for explaining the advances in genetics and clinical trials being conducted to combat the disease

]]>
http://www.idibell.cat/modul/news/ca/1016/a-group-of-lymphangioleiomyomatosis-lam-patients-attend-a-talk-on-the-disease-and-advances2017-09-13
New injectable antiretroviral treatment proved to be as effective as standard oral therapy ]]>http://www.idibell.cat/modul/news/ca/1015/new-injectable-antiretroviral-treatment-proved-to-be-as-effective-as-standard-oral-therapy2017-07-31El Grupo CataLands Solidaris da 10.000 euros al Programa ProCURE ]]>http://www.idibell.cat/modul/news/ca/1013/el-grupo-catalands-solidaris-da-10000-euros-al-programa-procure2017-07-31IDIBELL will foster three INPhINIT young researchers ]]>http://www.idibell.cat/modul/news/ca/1014/idibell-will-foster-three-inphinit-young-researchers2017-08-02Welcome Ducky, a social company committed to biomedical research ]]>http://www.idibell.cat/modul/news/ca/1012/welcome-ducky-a-social-company-committed-to-biomedical-research2017-07-25IDIBELL joins the Barcelona Bioinformatics Association ]]>http://www.idibell.cat/modul/news/ca/1011/idibell-joins-the-barcelona-bioinformatics-association2017-07-18Dr. Manel Esteller receives the Falcó Carlemany Award ]]>http://www.idibell.cat/modul/news/ca/1010/dr-manel-esteller-receives-the-falco-carlemany-award2017-07-14Nova eina d’anàlisi per a predir la resposta al tractament preoperatori en càncer de recte

Predir quins pacients no respondran al tractament pot ajudar a evitar-los efectes secundaris innecessaris i permetrà oferir-los alternatives més beneficioses, com poden ser la cirurgia programada amb major antel·lació o la participació en estudis clínics

]]>
http://www.idibell.cat/modul/news/ca/1009/nova-eina-danalisi-per-a-predir-la-resposta-al-tractament-preoperatori-en-cancer-de-recte2017-07-10
New epigenomic strategies in the clinical management of cancer of unknown primary ]]>http://www.idibell.cat/modul/news/ca/1008/new-epigenomic-strategies-in-the-clinical-management-of-cancer-of-unknown-primary2017-07-07A personalized treatment with metabolic therapy improves the motor and communication skills of a patient with atypical Rett syndrome ]]>http://www.idibell.cat/modul/news/ca/1007/a-personalized-treatment-with-metabolic-therapy-improves-the-motor-and-communication-skills-of-a-patient-with-atypical-rett-syndrome2017-07-05A new ribosomal biogenesis regulation point to treat cancer and 5q- syndrome ]]>http://www.idibell.cat/modul/news/ca/1005/a-new-ribosomal-biogenesis-regulation-point-to-treat-cancer-and-5q-syndrome2017-06-28Orgull en ciència: L’IDIBELL s’adhereix a la celebració del Dia per l’Alliberament LGTB+ ]]>http://www.idibell.cat/modul/news/ca/1004/orgull-en-ciencia-lidibell-sadhereix-a-la-celebracio-del-dia-per-lalliberament-lgtb-2017-07-04Dr. Xavier Matias-Guiu receives an ICS award for his research career ]]>http://www.idibell.cat/modul/news/ca/1006/dr-xavier-matias-guiu-receives-an-ics-award-for-his-research-career2017-06-29Facial paralysis image processing software is awarded a grant by the Academy of Medical Sciences ]]>http://www.idibell.cat/modul/news/ca/1003/facial-paralysis-image-processing-software-is-awarded-a-grant-by-the-academy-of-medical-sciences2017-06-16The complete epigenomes of the most frequent tumors, unveiled ]]>http://www.idibell.cat/modul/news/ca/1001/the-complete-epigenomes-of-the-most-frequent-tumors-unveiled2017-06-06IDIBELL leads a new European Innovative Training Network

 The four-year project will finance 15 early stage researchers to explain the relationship between cancer, metabolism and the immune system

]]>
http://www.idibell.cat/modul/news/ca/1000/idibell-leads-a-new-european-innovative-training-network2017-05-30
Scientists identify new predisposing genes and microRNAS involved in hereditary cancer

Dr. Gabriel Capellá presents the hereditary cáncer-related projects of IDIBELL at the XI AECC Symposium 

]]>
http://www.idibell.cat/modul/news/ca/999/scientists-identify-new-predisposing-genes-and-micrornas-involved-in-hereditary-cancer2017-05-18
IDIBELL and CMRB launch a new Catalan Regenerative Medicine Program

The Center of Regenerative Medicine in Barcelona (CMR[B]) - currently located within the Barcelona Biomedical Research Park (PRBB) - and the Bellvitge Biomedical Research Institute (IDIBELL) have joined efforts to create the new Regenerative Medicine Program of Catalonia (P-CMR[C]).

]]>
http://www.idibell.cat/modul/news/ca/998/idibell-and-cmrb-launch-a-new-catalan-regenerative-medicine-program2017-05-08
Starvation causes atypical cell death

Stress signals sent by the endoplasmic reticulum could explain the mechanism of cell death in the tumor core and during ischemic episodes

]]>
http://www.idibell.cat/modul/news/ca/996/starvation-causes-atypical-cell-death2017-05-03
IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day ]]>http://www.idibell.cat/modul/news/ca/995/idibell-and-ico-researchers-take-part-in-rcd-espanyols-heath-day2017-04-28Chemoresistance in breast cancer is associated with the modulation of tumor cell populations ]]>http://www.idibell.cat/modul/news/ca/994/chemoresistance-in-breast-cancer-is-associated-with-the-modulation-of-tumor-cell-populations2017-04-28IDIBELL researchers look for new drugs against melanoma ]]>http://www.idibell.cat/modul/news/ca/992/idibell-researchers-look-for-new-drugs-against-melanoma2017-04-21Researchers describe a new pathophysiological process of megalencephalic leukoencephalopathy (MLC) in astrocytes ]]>http://www.idibell.cat/modul/news/ca/993/researchers-describe-a-new-pathophysiological-process-of-megalencephalic-leukoencephalopathy-mlc-in-astrocytes2017-04-24Bellvitge research receives 1 million euros in PERIS 2016-2020 funding ]]>http://www.idibell.cat/modul/news/ca/990/bellvitge-research-receives-1-million-euros-in-peris-2016-2020-funding2017-04-11First photoactive drug for pain treatments

Experts from the Institute of Neurosciences of the University of Barcelona, the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Advanced Chemistry of Catalonia (IQAC) from CSIC, are designing the first light-operated drug to treat pain

]]>
http://www.idibell.cat/modul/news/ca/991/first-photoactive-drug-for-pain-treatments2017-04-11
An epigenetic lesion could be responsible for acute T-cell leukemia ]]>http://www.idibell.cat/modul/news/ca/989/an-epigenetic-lesion-could-be-responsible-for-acute-t-cell-leukemia2017-03-30The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer ]]>http://www.idibell.cat/modul/news/ca/988/the-it-liver-european-consortium-unveils-new-tgf-beta-functions-in-liver-cancer2017-03-28The research in Neurofibromatosis receives again the support of the city of Manlleu ]]>http://www.idibell.cat/modul/news/ca/986/the-research-in-neurofibromatosis-receives-again-the-support-of-the-city-of-manlleu2017-03-22After the epigenome: the epitranscriptome ]]>http://www.idibell.cat/modul/news/ca/987/after-the-epigenome-the-epitranscriptome2017-03-22The second edition of IDIBELL PhD day highlights the potential of young researchers ]]>http://www.idibell.cat/modul/news/ca/984/the-second-edition-of-idibell-phd-day-highlights-the-potential-of-young-researchers2017-03-20ICS visits IDIBELL ]]>http://www.idibell.cat/modul/news/ca/985/ics-visits-idibell2017-03-20Cryopreserved orthoxenografts broaden the scope of single cell sequencing technologies ]]>http://www.idibell.cat/modul/news/ca/982/cryopreserved-orthoxenografts-broaden-the-scope-of-single-cell-sequencing-technologies2017-03-15First large-scale interactome map of the largest membrane receptors group in humans ]]>http://www.idibell.cat/modul/news/ca/983/first-large-scale-interactome-map-of-the-largest-membrane-receptors-group-in-humans2017-03-15IDIBELL joins #HeForShe on International Women's Day ]]>http://www.idibell.cat/modul/news/ca/981/idibell-joins-heforshe-on-international-womens-day2017-03-10Lifestyle choices condition colon and rectal cancer risk more than genetics

The first risk prediction model based on data from the Spanish population is issued

]]>
http://www.idibell.cat/modul/news/ca/980/lifestyle-choices-condition-colon-and-rectal-cancer-risk-more-than-genetics2017-03-06
Barcelona will hold the new edition of the Congress of the Spanish Society of Pharmacology ]]>http://www.idibell.cat/modul/news/ca/979/barcelona-will-hold-the-new-edition-of-the-congress-of-the-spanish-society-of-pharmacology2017-03-01Zumba fundraiser for Rett Syndrome ]]>http://www.idibell.cat/modul/news/ca/978/zumba-fundraiser-for-rett-syndrome2017-03-15La Regata Carla presenta una segunda edición dinámica y solidaria

El dinero recaudado se destinará a la investigación sobre el Síndrome de Rett

]]>
http://www.idibell.cat/modul/news/ca/977/la-regata-carla-presenta-una-segunda-edicion-dinamica-y-solidaria2017-02-24
IDIBELL and the Integral Health Consortium begin a research integration process ]]>http://www.idibell.cat/modul/news/ca/976/idibell-and-the-integral-health-consortium-begin-a-research-integration-process2017-02-22La AECC-Cataluña otorga dos becas a investigadores IDIBELL en su Noche Solidaria ]]>http://www.idibell.cat/modul/news/ca/975/la-aecc-cataluna-otorga-dos-becas-a-investigadores-idibell-en-su-noche-solidaria2017-02-21Adenoviruses and the immune system join forces against cancer ]]>http://www.idibell.cat/modul/news/ca/974/adenoviruses-and-the-immune-system-join-forces-against-cancer2017-02-16Women and science: past, present and future ]]>http://www.idibell.cat/modul/news/ca/973/women-and-science-past-present-and-future2017-02-17Conference on health technologies within the Mobile World Congress framework ]]>http://www.idibell.cat/modul/news/ca/972/conference-on-health-technologies-within-the-mobile-world-congress-framework2017-02-10A Nature study reinforces the contribution of S6K1 kinase in obesity and aging

EPRS phosphorylation mediates S6K1-dependent metabolic responses related to obesity and aging

]]>
http://www.idibell.cat/modul/news/ca/971/a-nature-study-reinforces-the-contribution-of-s6k1-kinase-in-obesity-and-aging2017-02-08
100.000 pebrots contra el càncer ]]>http://www.idibell.cat/modul/news/ca/970/100000-pebrots-contra-el-cancer2017-02-03Bastos Medical, committed to IDIBELL’s ovarian cancer research ]]>http://www.idibell.cat/modul/news/ca/969/bastos-medical-committed-to-idibells-ovarian-cancer-research2017-02-01